Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Advanced Process Development And Manufacturing Solutions
Scaling complex chemical processes requires early risk identification, integrated safety and analytical expertise, and efficient tech transfer.
-
The 5-S Philosophy Driving Asymchem's Integrated TIDES Manufacturing
Manufacturing excellence drives complex therapies, with scale, speed, supply resilience, sustainability, and future readiness enabling development to reliable commercial production.
-
Coordinated Development As An Execution Framework
See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
Navigating Regulatory Barriers For CRISPR Gene Editing Therapies
Bringing CRISPR therapies to market requires navigating complex global regulations. Learn how strategic planning, risk assessment, and manufacturing alignment can streamline development.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Direct qPCR Amplification From Human Urine Samples
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
-
Direct Amplification Of Samples Associated With Strawberry Leaf Punches
Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.
-
Designing RNase H1 "Gapmer" Antisense Oligonucleotides
Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.
-
Comprehensive And Streamlined Genomic Signature Assessment
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
An Accelerated Protein Engineering Workflow Utilizing Linear DNA
Cell-free expression using linear DNA enables rapid protein production without cloning. See how strategic template design improves yield, supporting faster iteration and high-throughput screening.
FORMULATION DEVELOPMENT SOLUTIONS
- Scaling High-Potency APIs From Consulting To Containment
- Cutting-Edge Data Integration And Analytics Platform
- High-Content Screening System
- Solutions For Aggregate And Fragment Analyses
- Bioprocess Courses And Services
- Payload-Linker
- Gain Human-Relevant Insights With Patient-Derived Assay-Ready Organoids
- Eliminate Doubt With Chemistry Technical Services
- The Way Forward In Antibody Therapeutics Purification
- Gibco Efficient-Pro Medium And Feeds Evaluation Guide
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Veranova Appoints Dr. Bob Huang Vice President And General Manager Of West Deptford Site
- Leica Biosystems And CellCarta Expand Collaborative Companion Diagnostic Development Model To Accelerate Commercialization Globally
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Flexible Production: Körber Presents New Inspection And Packaging Innovations For The Global Market At Interpack
- Green Star Organic Milling Strengthens Food Safety Program With METTLER TOLEDO Metal Detector
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Notes From The Road: INTERPHEX 2026
- Compact & Powerful Double Planetary Mixer For Lab And Pilot-Scaling
- METTLER TOLEDO Strengthens Its Portfolio In The Americas And Europe With Eagle
- AES Cleanroom Technology appoints John Groth As Chief Revenue Officer